Researchers have divided breast cancer into four main molecular subtypes: luminal A (estrogen receptor (ER)+ , progesterone receptor (PR)+ , human epidermal growth factor receptor 2 (HER2)-), luminal B (ER+ , PR−), HER2 positive, and triple negative. This evidence concerns the gene PGR and breast carcinoma.